Inovio Pharmaceuticals Inc vs Kroger Co — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M), while Kroger Co trades at $56 (market cap $34.60B). The key difference: Kroger Co is far larger — about 454.7× Inovio Pharmaceuticals Inc's market cap, and Kroger Co pays a 2.55% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | KR | |
|---|---|---|
Market Cap | $76.09M | $34.60B |
Sector | Health | Consumer Staples |
52-Week High | $2.87 | $75.60 |
52-Week Low | $0.66 | $55.53 |
Enterprise Value | $47.10M | $54.70B |
Dividend Yield | — | 2.55% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →